RemeGen Co., Ltd.
REGMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $19 | $6 | $6 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $0 | $3 | $3 | $3 |
| Enterprise Value | $3 | $21 | $8 | $8 |
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -84.8% | 8.7% | 3.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 84.5% | 84.8% | 83.3% | 79.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14% | -18.4% | -32.2% | -64.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16.4% | -34.2% | -48.3% | -78.1% |
| EPS Diluted | -0.025 | -0.37 | -0.46 | -0.74 |
| % Growth | 93.2% | 19.6% | 37.8% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |